Skip to content
Screener

PTC Therapeutics PTCT Business Segments — Labor And Related Expense

Similar metrics at other companies

CryoPort, Inc. logo
CYRXLife Sciences Products — Labor And Related Expense
$6.06M+7.7%
CryoPort, Inc. logo
CYRXLife Sciences Services — Labor And Related Expense
$15.93M+21.4%
WAT
WATWaters Analytical And Materials Sciences — Labor And Related Expense
$159M+109%
Dillards logo
DDSConstruction — Labor And Related Expense
$1.84M+16.5%
Target Hospitality logo
THGovernment — Labor And Related Expense
$2.7M+87.4%
Orange County Bancorp logo
OBTBanking — Labor And Related Expense
$6.45M+12.9%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×
P/S+4.7×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001070081-26-000012
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Less:
Cost of product, collaboration and license sales19,6797,707
Program spend37,54448,158
Employee costs76,12167,699
Manufacturing costs9,08514,950
Administrative costs16,68818,414
Occupancy costs8,3547,183
Other segment items (a)107,889145,423

Item 1. Financial Statements (unaudited)

FAQ

What is PTC Therapeutics's business segments — labor and related expense?
PTC Therapeutics (PTCT) reported business segments — labor and related expense of $76.12M in Q1 2026.
How has PTC Therapeutics's business segments — labor and related expense changed year-over-year?
PTC Therapeutics's business segments — labor and related expense increased by 12.4% year-over-year, from $67.7M to $76.12M.
What is the long-term trend for PTC Therapeutics's business segments — labor and related expense?
Over 3 years (2022 to 2025), PTC Therapeutics's business segments — labor and related expense has grown at a -1.7% compound annual growth rate (CAGR), from $298.72M to $283.58M.
What does business segments — labor and related expense mean?
This includes all compensation, benefits, and payroll-related costs for personnel directly supporting the operations of the life science segment. It serves as a key indicator of the human capital investment required to sustain research, development, and commercial activities.

Ask your AI about PTC Therapeutics's business segments — labor and related expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude